Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Wound Biologics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Skin Substitutes
  • 1.3.3 Growth Factors
• 1.4 Market Segment by Application
  • 1.4.1 Global Wound Biologics Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Drugstore
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Wound Biologics Market Size
  • 2.1.1 Global Wound Biologics Revenue 2014-2025
  • 2.1.2 Global Wound Biologics Sales 2014-2025
• 2.2 Wound Biologics Growth Rate by Regions
  • 2.2.1 Global Wound Biologics Sales by Regions 2014-2019
  • 2.2.2 Global Wound Biologics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Wound Biologics Sales by Manufacturers
  • 3.1.1 Wound Biologics Sales by Manufacturers 2014-2019
  • 3.1.2 Wound Biologics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Wound Biologics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Wound Biologics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Wound Biologics Market Concentration Ratio (CR5 and HHI)
• 3.3 Wound Biologics Price by Manufacturers
• 3.4 Key Manufacturers Wound Biologics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Wound Biologics Market
• 3.6 Key Manufacturers Wound Biologics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Skin Substitutes Sales and Revenue (2014-2019)
  • 4.1.2 Growth Factors Sales and Revenue (2014-2019)
• 4.2 Global Wound Biologics Sales Market Share by Type
• 4.3 Global Wound Biologics Revenue Market Share by Type
• 4.4 Wound Biologics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Wound Biologics Sales by Application

6 United States

• 6.1 United States Wound Biologics Breakdown Data by Company
• 6.2 United States Wound Biologics Breakdown Data by Type
• 6.3 United States Wound Biologics Breakdown Data by Application

7 European Union

• 7.1 European Union Wound Biologics Breakdown Data by Company
• 7.2 European Union Wound Biologics Breakdown Data by Type
• 7.3 European Union Wound Biologics Breakdown Data by Application

8 China

• 8.1 China Wound Biologics Breakdown Data by Company
• 8.2 China Wound Biologics Breakdown Data by Type
• 8.3 China Wound Biologics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Wound Biologics Breakdown Data by Company
• 9.2 Rest of World Wound Biologics Breakdown Data by Type
• 9.3 Rest of World Wound Biologics Breakdown Data by Application
• 9.4 Rest of World Wound Biologics Breakdown Data by Countries
  • 9.4.1 Rest of World Wound Biologics Sales by Countries
  • 9.4.2 Rest of World Wound Biologics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Avita Medical
  • 10.1.1 Avita Medical Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.1.4 Wound Biologics Product Introduction
  • 10.1.5 Avita Medical Recent Development
• 10.2 ConvaTec
  • 10.2.1 ConvaTec Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.2.4 Wound Biologics Product Introduction
  • 10.2.5 ConvaTec Recent Development
• 10.3 Acelity
  • 10.3.1 Acelity Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.3.4 Wound Biologics Product Introduction
  • 10.3.5 Acelity Recent Development
• 10.4 Cytori Therapeutic
  • 10.4.1 Cytori Therapeutic Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.4.4 Wound Biologics Product Introduction
  • 10.4.5 Cytori Therapeutic Recent Development
• 10.5 MacroCure
  • 10.5.1 MacroCure Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.5.4 Wound Biologics Product Introduction
  • 10.5.5 MacroCure Recent Development
• 10.6 Nuo Therapeutics
  • 10.6.1 Nuo Therapeutics Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.6.4 Wound Biologics Product Introduction
  • 10.6.5 Nuo Therapeutics Recent Development
• 10.7 Molyncke Health Care
  • 10.7.1 Molyncke Health Care Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.7.4 Wound Biologics Product Introduction
  • 10.7.5 Molyncke Health Care Recent Development
• 10.8 Osiris Therapeutics
  • 10.8.1 Osiris Therapeutics Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.8.4 Wound Biologics Product Introduction
  • 10.8.5 Osiris Therapeutics Recent Development
• 10.9 Smith And Nephew
  • 10.9.1 Smith And Nephew Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.9.4 Wound Biologics Product Introduction
  • 10.9.5 Smith And Nephew Recent Development
• 10.10 Organogenesis
  • 10.10.1 Organogenesis Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Wound Biologics
  • 10.10.4 Wound Biologics Product Introduction
  • 10.10.5 Organogenesis Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Wound Biologics Sales Channels
  • 11.2.2 Wound Biologics Distributors
• 11.3 Wound Biologics Customers

12 Market Forecast

• 12.1 Global Wound Biologics Sales and Revenue Forecast 2019-2025
• 12.2 Global Wound Biologics Sales Forecast by Type
• 12.3 Global Wound Biologics Sales Forecast by Application
• 12.4 Wound Biologics Forecast by Regions
  • 12.4.1 Global Wound Biologics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Wound Biologics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

The wound healing is a complex process that involves the activation and synchronization of intracellular, and extracellular elements. Wound is healed with tissue regeneration and scar formation. Wound biologic healing helps in re-establishment of the natural repair mechanisms, which includes the application of active biological agents, such as plant-derived active biomolecules which reveal antioxidant, antimicrobial, or anti-inflammatory attributes.
Among the geographies, North America is expected to be the largest market for wound biologics followed by Europe. growing occurrence of chronic diseases and rising demand for recombinant factors are likely to propel the growth in this region. While, Asia-Pacific is expected to grow fast during the forecast period owing to high prevalence of diabetic patients in Asian countries.
In 2019, the market size of Wound Biologics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Wound Biologics.

This report studies the global market size of Wound Biologics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Wound Biologics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis

Market Segment by Product Type
Skin Substitutes
Growth Factors

Market Segment by Application
Hospital
Drugstore
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Wound Biologics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Wound Biologics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Wound Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025